Form 4/A for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2026-03-09 00:00:00 ET · period of report 2026-03-03 · accession 0001193125-26-099007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-03-09 | 2026-03-03 | VRDN | Mahoney Stephen F. | Pres, CEO, Dir | F - Tax | $30.19 | -7,408 | 33.3K | -18% | -$223.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | F | D | 7,408 | $30.19 | 33,349 | D | — | — | (F1) This amendment corrects the number of shares and price sold to cover taxes on the initial Form 4 filed on March 4, 2026, as well as the resulting total number of shares beneficially owned following all transactions reported in the initial Form 4. |